Comparison of Reimbursement Fees for Most Frequent Clinical Laboratory Tests: Slovakia vs EU Countri

From: Gustav Kovac, For: Claude Cohen, Stelios Chatzi, Augusto Machado, Pierre Langlois, Per Hyltoft Petersen, Wytze Oosterhuis, Matthias Orth, Gabor Kovacs, Attilla Miszeta Date: 2. 5. 2017 Introduction The goal for comparison was to gain an overview on most frequently used clinical laboratory tests in countries throughout the EU. Method Appeal for Cooperation From: prof MUDr RNDr Gustav Kovac CSc MBA To: Members of Section and Board for Laboratory Medicine UMES Date: 16. 2. 2017 Introduction Slovak Society for Laboratory Medicine ( SSLM ) prepares for negotiations with Slovak Health Insurance Companies on Revision of Reimbursement fees for laboratory tests Method one of the basic prerequisites for being good prepared is the knowledge on reibursement fees in other countries in the EU Result we are asking you to provide us with information on reimbursement fees for 20 most frequent laboratory tests in Slovakia ( see the attached file Discussion the negotiations are planned to start at 6th March 2016 SSLM would be happy to receive the support from members / representatives of the section and board for Laboratory Medicine UEMS – if possible Conclusion Help us in that you fill out the table in the attached file – if posible, please Reccommendations for any question or comments use Table Results Discussion COMMENTS FROM PARTICIPANTS PROVIDING REIMBURSEMENT FEES France ( Claude Cohen ) These prices are public however, it is necessary to remain careful and not to spread them beyond those who participated in it. Greece ( Stelios Chatzi ) The prices are form the official website of the Ministry of Health. They are now up to revise fee-list in terms of rationalization: some prices are higher and some are lower than they should be. Portugal ( Augusto Machado ) The whole fee for services catalogue and explanation directive has been promptly provided. Interesting is, for each test has the patient to pay approximately 10-20% of total price. The rest is payed from the state / health insurance company Belgium ( Michel Langlois ) Belgium representative ( EFLM ) provided required data promptly Sweden ( Per Hyltoft Petersen ) Two lists of prices from two counties in the South of Sweden (Blekinge and Halland). The Swedish currency: 9.5 kronor corresponds to approximately 1 Euro. The prices from the two counties are not identically, e.g. Serum Ca and serum Albumin cost 15.36 kr in Blekinge and 5 kr in Halland, IgG, IgA and IgM are close 23.55 and 26 kr, and serun testosterone 107.00 and 60 kr. The Netherlands ( Wytze Oosterhuis ) Whole list of more than laboratory tests and reimbursement fees has been provided. It contains approximately more than 400 laboratory tests in consolidatet form. It could be taken as a model for simplification of laboratory test catalogue in Slovakia. Germany ( Matthias Orth ) EBM2000 (Einheitlicher Bewertungsmassstab -- uniform valuation schedule) Subtract 10% of the prices for the real reimbursement, right now they are trying to get payment down to only 80% of the prices in the list (which ist 20 Cent for a clinical chemistry test including HDL and LDL). The GOÄ (Gebührenordnung für Ärzte -- Physicians' tariff) is a law. Everything is paid in points (a point is worth 0.059 Cent) and you are allowed to increase the price by a factor (which is 1.15 but in some case the factor is only 0.8 so actually the payment gets lower when the "increasing factor" is applied). The lab tests have the numbers 3500-4787. Use the points for comparison, the prices given in the law in the last columng are still in German Marks (2 German Marks DM are about 1 EUR). Enclosed are more tests with our different tariffs. This figure compares Theranos pricing with EBM2000 and GOÄ. When it comes to put money behind certain tests, it is rather critical to look at the whole picture. In clinical chemistry, nobody can survive from a reimbursement of 0.22 Cent for LDL or HDL (the reagent is by far more expensive and the technicians also ask for their paycheck). In Germany the whole calculation is based on CRP and on some rather frequent tests (like Vitamin D). In addition, if they have only few patients which get invoices after GOÄ this will also compensate for the losses in EBM2000. My suggestion is to look for the tests which generate ~80% of your revenues (in our labs these are about 200 different tests) and then look for the effects of changes in reimbursement. It is rather dangerous to present the lowest costs among different countries -- then there will be no way to compensate for the losses. By the way, the prices of Theranos were multifold higher than our EBM2000. Hungary ( Gabor Kovacs, Attilla Miszetta ) The similar informations on reimbursement fees provided promptly from two sources PARTICIPANTS PROVIDING ONLY COMMENTS UK ( Ian Watson ) The UK does not have a reimbursement based system for laboratory tests. The Government believe that pathology should cost 1.6% of a hospital’s budget, this includes providing services to the community. This makes no allowance for anything other than routine tests. The Carter Report on pathology had ‘baskets of tests’ based on cost, but this is 10 years old and probably not relevant to us. Denmark ( Per Hyltoft Petersen ) It seems to be rather difficult to get the information on reimbursement fees. Finland ( Ilkka Mononen ) In Finland the test prices vary from lab to lab. In the public sector, the lab test prices are included in the flat fee that the patient pays for the visit to the doctor. In the private sector, the patients pays for both the lab tests and the visit to the doctor and the fees vary from one service provider to another. Depending on the situation, the patient may get some reimbursement from the government from the private sector costs. Wales ( Ian Frayling ) The Wales representative is on sabbatical leave until end of April. Italy ( Francesco Verna ) Health care system in Italy is decentralized: each region has it’s own rules. That is valid also for the reimbursement. Up to that time no information was available Conclusion 1 On the comparison / cooperation study participated 14 EU Countries ( from 28 countries asked ) 9 provided information on reimbursmenet fees and comments ( France, Greece, Portugal, Belgium, Sweden, The Netherlands, Germany, Slovakia, Hungary ) 5 provided only comments on reimbursement systems ( UK, Danmark, Finland, Wales, Italy ) 2 38 most frequently tests used in Slovakia were evaluated 3 The average ( non weighted ) reimbursement fee for 1 laboratory test for EU is 3,26 EUR 4 The avergae ( non weighted ) reimbursement fees for individual conuntry France [ 5, 71 EUR ] Greece [ 4,90 EUR ] Portugal [ 4,71 EUR ] Belgium [ 3,96 EUR ] Sweden [ 2,90 EUR ] Netherlands [ 2,78 EUR ] Sweden [ 2,40 EUR ] Germany [ 1,98 EUR ] Slovakia [ 1,69 EUR ] Hungary [ 1,55 EUR ] 5 The „Test Categories“ 1 EUR Tests Category ( „Routine Chemistry“ ) creatitine, AST, glucose, GGT, ALT, urea, sodium, potassium, bilirubin, cholesterol, triglycerides, alkaline phosphatase, chloride, uric acid, calcium, total protein 2 EUR Tests Category ( „Special Chemistry“ ) LDL, HDL, uric acid, total protein 4 EUR Tests Category ( „Hematology, Microscopy“ ) CRP, fibrinogen, urine sediment, IgG, IgA, IgM, APTT, fibrinogen, CBC 3-5 8 EUR Tests Category ( „Immunoserology“ ) hepatitis, treponema, HIV, ANA, ENA, IgE 10 EUR Tests Category ( „Molecular Biology“ ) DNA, transglutaminase Recommendations 1 Proposal for further steps Discussion on comming UEMS LM Section and Board meeting in Faro Test catalogue consolidation according and the Netherlands catalogue Discussion on Portugal payment system Increasing number of participants 2 Recommendation from Matthias Orth look for the tests which generate 80% of revenues and then look for the effects of changes in reimbursement it is rather dangerous to present the lowest costs among different countries - then there will be no way to compensate for the losses.

Web: Slovenská spoločnosť pre laboratórnu medicínu - SSLM | LAB-MED.sk
Aktualizované: 24.11.2023

prejsť na článok

Comparison of Reimbursement Fees for Most Frequent Clinical Laboratory Tests: Slovakia vs EU Countri

Non-invasive prenatal testing (NIPT) by low coverage genomic sequencing: Detection limits of screened chromosomal microdeletions

Identification of Structural Variation from NGS-Based Non-Invasive Prenatal Testing

Non-invasive prenatal testing as a valuable source of population specific allelic frequencies

Comments of the Slovak Society for Laboratory Medicine ( SSLM ) to the EFLM Accreditation Proposal

List of Top IAS Coaching Centers in Hyderabad